Boone Capital Management LLC Takes Position in Teleflex Incorporated $TFX

Boone Capital Management LLC acquired a new stake in Teleflex Incorporated (NYSE:TFX) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 387,388 shares of the medical technology company’s stock, valued at approximately $49,105,000. Teleflex makes up 11.5% of Boone Capital Management LLC’s portfolio, making the stock its largest holding.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in TFX. Kelleher Financial Advisors bought a new position in shares of Teleflex in the second quarter valued at approximately $25,000. Banque Cantonale Vaudoise boosted its holdings in shares of Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after buying an additional 113 shares during the period. UMB Bank n.a. grew its stake in Teleflex by 57.1% in the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after buying an additional 113 shares during the last quarter. Allworth Financial LP acquired a new position in Teleflex in the 2nd quarter valued at $44,000. Finally, Kestra Advisory Services LLC bought a new position in Teleflex in the 4th quarter worth $45,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Price Performance

Shares of Teleflex stock opened at $138.69 on Thursday. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.60 and a quick ratio of 2.12. Teleflex Incorporated has a fifty-two week low of $100.18 and a fifty-two week high of $145.00. The firm has a fifty day moving average price of $133.39 and a two-hundred day moving average price of $125.61. The company has a market cap of $5.88 billion, a PE ratio of -5.95, a price-to-earnings-growth ratio of 0.93 and a beta of 0.81.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.48. The company had revenue of $570.33 million for the quarter, compared to the consensus estimate of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The business’s revenue was up 28.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Analysts expect that Teleflex Incorporated will post 7.26 EPS for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, August 14th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.0%. The ex-dividend date is Friday, August 14th. Teleflex’s payout ratio is currently -5.84%.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on TFX shares. Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and boosted their target price for the stock from $135.00 to $155.00 in a research report on Friday, May 8th. Wall Street Zen upgraded Teleflex from a “sell” rating to a “hold” rating in a research note on Sunday, August 9th. Mizuho lifted their price objective on Teleflex from $140.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 15th. BMO Capital Markets initiated coverage on Teleflex in a research report on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price objective for the company. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Teleflex in a research note on Wednesday, June 24th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Teleflex has an average rating of “Hold” and a consensus target price of $152.90.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.